Progesterone and Its Metabolites Play a Beneficial Role in Affect Regulation in the Female Brain.
Level 5 - mechanism / opinion, no new human data
narrative review without systematic search or meta-analytic methodology
PubMed 37111278 · doi:10.3390/ph16040520
What was done
This narrative review summarizes mechanistic, physiological, and clinical literature regarding the role of progesterone and its metabolite allopregnanolone in female mood regulation, focusing on premenstrual dysphoric disorder, postpartum depression, and perimenopausal affect, as well as the mechanistic differences between bioidentical progesterone and synthetic progestins.
What was found
The abstract reports no numerical data, sample sizes, or effect estimates. It describes that allopregnanolone binds to GABA-A receptors at nanomolar concentrations to produce antidepressant, anxiolytic, and sedative actions. It notes that synthetic progestins can paradoxically worsen mood because their chemical structure prevents metabolism to neuroactive derivatives and their use suppresses endogenous ovarian endocrine function.
Why it matters
The paper outlines the neurobiological basis for why natural progesterone derivatives and synthetic progestins have divergent effects on female mood regulation, framing allopregnanolone-pathway interventions for reproductive affective disorders.
Limits
As a narrative review, it presents no primary clinical data, quantitative meta-analyses, or systematic inclusion criteria. Specific effect sizes, risk of bias assessments, and treatment populations are not reported in the abstract.
Cited by
- supports Topical progesterone administration does not provide the allopregnanolone neurosteroid benefit associated with other delivery forms.